NYSE:GEHC

GE HealthCare stock closes at $84 after new FDA MRI clearances — what investors watch next week

GE HealthCare shares closed at $84.23 Friday, up 1.47%, marking a five-session winning streak. The company reported FDA 510(k) clearance for two new MRI systems and an AI-enabled workflow platform this week. Management will address investors on Feb. 26 and March 10. Trading volume topped 5 million shares as markets rose.

21 February 2026

NYSE:GEHC·Stock Market

AI Was Supposed to Replace Radiologists by 2025 – Here’s Why It Didn’t

About 75% of FDA-cleared medical AI devices target radiology, but radiologist jobs remain secure and shortages persist. Current AI tools handle narrow imaging tasks like flagging strokes or measuring lesions, but cannot replace human expertise or generalize across cases. Over 520 radiology AI devices have U.S. approval, yet regulatory, legal, and payment hurdles slow adoption. Most experts now view AI as an aid, not a replacement.

31 August 2025

Artificial Intelligence·NYSE:GEHC·Technology

Brown & Brown (BRO) Stock Falls 44% in a Year: Is It Undervalued?
March 20, 2026, 1:37 PM EDT. Brown & Brown (BRO) shares have dropped 44% over the past year, sparking investor debate on fair value. The insurance intermediary's stock trades at $66.56, down 14.2% year-to-date but up 50% over five years. Valuation metrics show mixed signals; BRO is undervalued on four of six checks with a valuation score of 4/6. An Excess Returns model places intrinsic value at around $141.82 per share, implying the stock may be trading at a 53.1% discount. Using price-to-earnings (P/E) ratio analysis, investors weigh growth expectations against risks amid sector reassessment. Brown & Brown's valuation amid market pressure highlights divergent investor views on its current and future profitability in the insurance sector.